Genomic landscapes of breast fibroepithelial tumors

Nature Genetics

Volumn 47, Issue 11, 2015, Pages 1341-1345

  Tan, Jing ^a,b   Ong, Choon Kiat ^a,b   Lim, Weng Khong ^a,b   Ng, Cedric Chuan Young ^a,b   Thike, Aye Aye ^c   Ng, Ley Moy ^d   Rajasegaran, Vikneswari ^a,b   Myint, Swe Swe ^a,b   Nagarajan, Sanjanaa ^a,b   Thangaraju, Saranya ^a,b   Dey, Sucharita ^d   Md Nasir, Nur Diyana ^c   Wijaya, Giovani Claresta ^a,b   Lim, Jing Quan ^a,b   Huang, Dachuan ^a,b   Li, Zhimei ^a,b   Wong, Bernice Huimin ^a   Chan, Jason Yong Sheng ^a   McPherson, John R ^b   Cutcutache, Ioana ^b   Poore, Gregory ^e   Tay, Su Ting ^b   Tan, Wai Jin ^c   Putti, Thomas Choudary ^f   Ahmad, Buhari Shaik ^g   Iau, Philip ^g   Chan, Ching Wan ^g   Tang, Anthony P H ^g   Yong, Wei Sean ^a,c,h   Madhukumar, Preetha ^a,c,h   Ho, Gay Hui ^a,c,h   Tan, Veronique Kiak Mien ^a,c,h   Wong, Chow Yin ^a,c,h   Hartman, Mikael ^g,h,i   Ong, Kong Wee ^a,c,h   Tan, Benita K T ^a,c,h   Rozen, Steven G ^b   Tan, Patrick ^b,d,j   Tan, Puay Hoon ^c   Teh, Bin Tean ^a,b,d,k   more..

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

^c SINGAPORE GENERAL HOSPITAL   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e Duke University   (United States)

^f NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^g NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^h NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

ⁱ KAROLINSKA INSTITUTE   (Sweden)

^j GENOME INSTITUTE OF SINGAPORE   (Singapore)

^k INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

more..

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 4; FILAMIN A; MED12 PROTEIN; PROTEIN; RETINOIC ACID RECEPTOR; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; FILAMIN; FLNA PROTEIN, HUMAN; MED12 PROTEIN, HUMAN; MEDIATOR COMPLEX; MLL2 PROTEIN, HUMAN; RETINOIC ACID RECEPTOR ALPHA; TUMOR PROTEIN;

ARTICLE; BREAST EPITHELIUM; BREAST FIBROEPITHELIAL TUMOR; BREAST TUMOR; CONTROLLED STUDY; CYSTOSARCOMA PHYLLOIDES; FEMALE; GENE SEQUENCE; HEK293 CELL LINE; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; MISSENSE MUTATION; PRIORITY JOURNAL; SOMATIC MUTATION; TRANSCRIPTION INITIATION; ADOLESCENT; ADULT; AGED; EXOME; FIBROADENOMA; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HIGH THROUGHPUT SEQUENCING; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; PROCEDURES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BASE SEQUENCE; BREAST NEOPLASMS; DNA-BINDING PROTEINS; EXOME; FEMALE; FIBROADENOMA; FILAMINS; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HEK293 CELLS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; MEDIATOR COMPLEX; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; PHYLLODES TUMOR; RECEPTORS, RETINOIC ACID; YOUNG ADULT;

EID: 84945493573     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.3409     Document Type: Article

References (50)

1. Lakhani, S., Ellis, I., Schnitt, S., Tan, P., & Van de Vijver, M. World Health Organisation Classification of Tumors of the Breast vol. 4, 142-147 (International Agency for Research on Cancer, 2012).
2. Lim, W.K., et al. Exome sequencing identifies highly recurrent MED12 somatic mutations in breast fibroadenoma. Nat. Genet. 46, 877-880 (2014).
3. Nagasawa, S., et al. MED12 exon 2 mutations in phyllodes tumors of the breast. Cancer Med. 4, 1117-1121 (2015).
4. Piscuoglio S., et al. MED12 somatic mutations in fibroadenomas and phyllodes tumours of the breast. Histopathology doi:10.1111/his.12712 8 April 2015).
5. Yoshida, M., et al. Frequent MED12 mutations in phyllodes tumours of the breast. Br. J. Cancer 112, 1703-1708 (2015).
6. Lien H.C., Huang, C.S., Yang, Y.W., & Jeng, Y.M. Mutational analysis of MED12 exon 2 in a spectrum of fibroepithelial tumours of the breast: implications for pathogenesis and histogenesis. Histopathology doi:10.1111/his.12764 25 June 2015).
7. Ng, C.C., et al. MED12 is frequently mutated in breast phyllodes tumours: a study of 112 cases. J. Clin. Pathol. 68, 685-691 (2015).
8. Tan, P.H., et al. Phyllodes tumors of the breast: the role of pathologic parameters. Am. J. Clin. Pathol. 123, 529-540 (2005).
9. Krishnamurthy, S., Ashfaq, R., Shin, H.J., & Sneige, N. Distinction of phyllodes tumor from fibroadenoma: a reappraisal of an old problem. Cancer 90, 342-349 (2000).
10. Hodges, K.B., et al. Evidence for transformation of fibroadenoma of the breast to malignant phyllodes tumor. Appl. Immunohistochem. Mol. Morphol. 17, 345-350 (2009).
11. Kuijper, A., et al. Analysis of the progression of fibroepithelial tumours of the breast by PCR-based clonality assay. J. Pathol. 197, 575-581 (2002).
12. Noguchi, S., et al. Progression of fibroadenoma to phyllodes tumor demonstrated by clonal analysis. Cancer 76, 1779-1785 (1995).
13. Kasami, M., et al. Monoclonality in fibroadenomas with complex histology and phyllodal features. Breast Cancer Res. Treat. 50, 185-191 (1998).
14. Abe, M., et al. Malignant transformation of breast fibroadenoma to malignant phyllodes tumor: long-Derm outcome of 36 malignant phyllodes tumors. Breast Cancer 18, 268-272 (2011).
15. Cani, A.K., et al. Next-gen sequencing exposes frequent MED12 mutations and actionable therapeutic targets in phyllodes tumors. Mol. Cancer Res. 13, 613-619 (2015).
16. Tan, W.J., et al. Novel genetic aberrations in breast phyllodes tumours: comparison between prognostically distinct groups. Breast Cancer Res. Treat. 145, 635-645 (2014).
17. Jones, A.M., et al. A comprehensive genetic profile of phyllodes tumours of the breast detects important mutations, intra-Dumoral genetic heterogeneity and new genetic changes on recurrence. J. Pathol. 214, 533-544 (2008).
18. Cancer Genome Atlas Network Comprehensive molecular portraits of human breast tumours Nature 490 61-70 2012).
19. Banerji, S., et al. Sequence analysis of mutations and translocations across breast cancer subtypes. Nature 486, 405-409 (2012).
20. Curtis, C., et al. The genomic and transcriptomic architecture of 2, 000 breast tumours reveals novel subgroups. Nature 486, 346-352 (2012).
21. Stephens, P.J., et al. The landscape of cancer genes and mutational processes in breast cancer. Nature 486, 400-404 (2012).
22. Boeva, V., et al. Multi-factor data normalization enables the detection of copy number aberrations in amplicon sequencing data. Bioinformatics 30, 3443-3450 (2014).
23. Boeva, V., et al. Control-FREEC: a tool for assessing copy number and allelic content using next-generation sequencing data. Bioinformatics 28, 423-425 (2012).
24. Miller, C.A., et al. SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution. PLoS Comput. Biol. 10, e1003665 (2014).
25. Mäkinen, N., et al. MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas. Science 334, 252-255 (2011).
26. Barbieri, C.E., et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat. Genet. 44, 685-689 (2012).
27. Assié, G., et al. Integrated genomic characterization of adrenocortical carcinoma. Nat. Genet. 46, 607-612 (2014).
28. Zhu, H.H., Qin, Y.Z., & Huang, X.J. Resistance to arsenic therapy in acute promyelocytic leukemia. N. Engl. J. Med. 370, 1864-1866 (2014).
29. Kang, Y.K., Guermah, M., Yuan, C.X., & Roeder, R.G. The TRAP/Mediator coactivator complex interacts directly with estrogen receptors a and b through the TRAP220 subunit and directly enhances estrogen receptor function in vitro. Proc. Natl. Acad. Sci. USA 99, 2642-2647 (2002).
30. Ross-Innes, C.S., et al. Cooperative interaction between retinoic acid receptor-A and estrogen receptor in breast cancer. Genes Dev. 24, 171-182 (2010).
31. Savoy, R.M., & Ghosh, P.M. The dual role of filamin A in cancer: can't live with (too much of) it, can't live without it. Endocr. Relat. Cancer 20, R341-R356 (2013).
32. Nakamura, F., Osborn, T.M., Hartemink, C.A., Hartwig, J.H., & Stossel, T.P. Structural basis of filamin A functions. J. Cell Biol. 179, 1011-1025 (2007).
33. Zhu, X., et al. Identification of functional cooperative mutations of SETD2 in human acute leukemia. Nat. Genet. 46, 287-293 (2014).
34. Pasqualucci, L., et al. Analysis of the coding genome of diffuse large B-cell lymphoma. Nat. Genet. 43, 830-837 (2011).
35. Cimino-Mathews, A., et al. A subset of malignant phyllodes tumors harbors alterations in the Rb/p16 pathway. Hum. Pathol. 44, 2494-2500 (2013).
36. Feakins, R.M., Mulcahy, H.E., Nickols, C.D., & Wells, C.A. p53 expression in phyllodes tumours is associated with histological features of malignancy but does not predict outcome. Histopathology 35, 162-169 (1999).
37. Millar, E.K., et al. Malignant phyllodes tumours of the breast display increased stromal p53 protein expression. Histopathology 34, 491-496 (1999).
38. Sawyer, E.J., et al. Molecular analysis of phyllodes tumors reveals distinct changes in the epithelial and stromal components. Am. J. Pathol. 156, 1093-1098 (2000).
39. Jara-Lazaro, A.R., & Tan, P.H. Molecular pathogenesis of progression and recurrence in breast phyllodes tumors. Am. J. Transl. Res. 1, 23-34 (2009).
40. Cerami, E., et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401-404 (2012).
41. Altucci, L., & Gronemeyer, H. The promise of retinoids to fight against cancer. Nat. Rev. Cancer 1, 181-193 (2001).
42. Markowski, D.N., et al. MED12 mutations in uterine fibroids-Dheir relationship to cytogenetic subgroups. Int. J. Cancer 131, 1528-1536 (2012).
43. Chan-On, W., et al. Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers. Nat. Genet. 45, 1474-1478 (2013).
44. Thorvaldsdóttir, H., Robinson, J.T., & Mesirov, J.P. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief. Bioinform. 14, 178-192 (2013).
45. Saunders, C.T., et al. Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs. Bioinformatics 28, 1811-1817 (2012).
46. Sherry, S.T., et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 29, 308-311 (2001).
47. Ng, P.C., & Henikoff, S. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res. 31, 3812-3814 (2003).
48. Reva, B., Antipin, Y., & Sander, C. Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res. 39, e118 (2011).
49. Choi, Y., & Chan, A.P. PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics 31, 2745-2747 (2015).
50. Carter, H., et al. Cancer-specific high-Dhroughput annotation of somatic mutations: computational prediction of driver missense mutations. Cancer Res. 69, 6660-6667 (2009).